Ldr. Thompson et al., Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas - A clinicopathologic study of 130 cases, AM J SURG P, 23(1), 1999, pp. 1-16
Citations number
108
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Mucinous cystic neoplasms (MCNs) of the pancreas are uncommon tumors. The c
lassification and biologic potential of these neoplasms remain the subject
of controversy. Attempts to classify these tumors in a similar manner to ov
arian MCNs remains controversial, as even histologically benign-appearing p
ancreatic MCNs metastasize and are lethal. One hundred thirty cases of MCNs
were identified in the files of the Endocrine Pathology Tumor Registry of
the Armed Forces Institute of Pathology from the years 1979 to 1993. The pa
thologic features, including hematoxylin and eosin staining, histochemistry
, immunohistochemistry (IHC), cell cycle analysis, and K-ras oncogene deter
mination were reviewed. These findings were correlated with the clinical fo
llow-up obtained in all cases. There were 130 women, aged 20-95 years (mean
age at the outset, 44.6 years). The patients had vague abdominal pain, ful
lness, or abdominal masses. More than 95% of the tumors were in the pancrea
tic tail or body and were predominantly multilocular. The tumors ranged in
size from 1.5 to 36 cm in greatest dimension, with the average tumor measur
ing >10 cm. A spectrum of histomorphologic changes were present within the
same case and from case to case. A single layer of bland-appearing, sialomu
cin-producing columnar epithelium lining the cyst wall would abruptly chang
e to a complex papillary architecture, with and without cytologic atypia, a
nd with and without stromal invasion. Ovarian-type stroma was a characteris
tic and requisite feature. Focal sclerotic hyalinization of the stroma was
noted. This ovarian-type stroma reacted with vimentin, smooth muscle actin,
progesterone, or estrogen receptors by MC analysis. There was no specific
or unique epithelial IHC. K-ras mutations by sequence analysis were wild ty
pe in all 52 cases tested. Ninety percent of patients were alive or had die
d without evidence of disease (average follow-up 9.5 years), irrespective o
f histologic appearance; 3.8% were alive with recurrent disease (average 10
years after diagnosis); and 6.2% died of disseminated disease (average 2.5
years from diagnosis). Irrespective of the histologic appearance of the ep
ithelial component, with or without stromal invasion, pancreatic MCNs shoul
d all be considered as mucinous cystadenocarcinomas of low-grade malignant
potential. Pancreatic MCNs cannot be reliably or reproducibly separated int
o benign, borderline, or malignant categories.